Safety, efficacy main concerns with Russia's COVID-19 vaccine: Nobel laureate Peter Doherty

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in Phase 3 or larger clinical trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2DROOUl
via IFTTT